Full Press Release Details
Regeneron Closes $312 Million Common Stock Sale in Connection with Sanofi-Aventis Collaboration.
REGN
Regeneron Closes $312 Million Common Stock Sale in Connection with Sanofi-Aventis Collaboration
Key Takeaway: Regeneron Closes $312 Million Common Stock Sale in Connection with Sanofi-Aventis Collaboration